Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: Role of glucose-induced PKC activity

Molecular and Cellular Biochemistry

Volumn 262, Issue 1-2, 2004, Pages 155-163

  Davidoff, Amy J ^a   Davidson, Michael B ^a   Carmody, Marybeth W ^a   Davis, Mari Elena ^a   Ren, Jun ^b,c  

^a UNIVERSITY OF NEW ENGLAND   (United States)

^b UNIVERSITY OF WYOMING   (United States)

^c UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Contractile function; Diabetes; Myocyte insulin resistance; Protein kinase C

Indexed keywords

CHELERYTHRINE; DEOXYGLUCOSE; GLUCOSE; INSULIN; PROTEIN KINASE C; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME INDUCTION; GLUCOSE TRANSPORT; HEART CELL CULTURE; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HEART VENTRICLE; HORMONAL REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; MUSCLE FIBER CULTURE; NONHUMAN; PROTEIN FUNCTION; RAT; STREPTOZOCIN DIABETES; VISUAL AID;

ANIMALS; BIOMECHANICS; CELL SHAPE; CELLS, CULTURED; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUCOSE; HEART VENTRICLES; INSULIN RESISTANCE; MALE; MICROSCOPY, VIDEO; MUSCLE CELLS; PROTEIN KINASE C; RATS; RATS, WISTAR;

ANIMALIA;

EID: 4344692221     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000038231.68078.4b     Document Type: Article

References (46)

1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 100: 1134-1146, 1999
2. Chatham JC, Forder JR, McNeill JH: The Heart in Diabetes. Norwell, MA: Kluwer Academic Publishers, 1996
3. 2+ handling in ventricular myocytes isolated from diabetic rats. Am J Physiol 270: H1529-H1537, 1996
4. Ren J, Davidoff AJ: Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272: H148-H158, 1997
5. 2+ in the heart during diabetes. Cardiovasc Res 34: 41-47, 1997
6. Dhalla NS, Pierce GN, Innes IR, Beamish RE: Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1: 263-281, 1985
7. Dillmann WH: Diabetes and thyroid hormone-induced changes in cardiac function and their molecular basis. Ann Rev Med 40: 373-394, 1989
8. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 34: 129-136, 1997
9. Zhong Y, Ahmed S, Grupp IL, Matlib MA: Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol 281: H1137-H1147, 2001
10. Idris I, Gray S, Donnelly R: Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44: 659-673, 2001
11. Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M: Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: Alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. JPET 282: 475-484, 1997
12. + currents in rat ventricular myocytes. Circ Res 74: 620-628, 1994
13. Davidoff AJ, Ren J: Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol 272: H159-H167, 1997
14. Ren J, Gintant GA, Miller RE, Davidoff AJ: High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol 273: H2876-H2883, 1997
15. Dutta K, Carmody MW, Cala SE, Davidoff AJ: Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J Mol Cell Cardiol 34: 985-996, 2002
16. Xiang H, McNeill JH: Protein kinase C activity is altered in diabetic rat hearts. Biochem Biophys Res Commun 187: 703-710, 1992
17. Malhotra A, Reich D, Reich D, Nakouzi A, Sanghi V, Geenen D, Buttrick P: Experimental diabetes is associated with functional activation of protein kinase CE and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81: 1027-1033, 1997
18. Giles TD, Ouyang J, Kerut EK, Given MB, Allen GE, McIlwain EF, Greenberg SS: Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am J Physiol 274: H295-H307, 1998
19. Liu X, Wang J, Takeda N, Binaglia L, Panagia V, Dhalla N: Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am J Physiol 277: E798-E804, 1999
20. Mackay K, Mochly-Rosen D: Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol 33: 1301-1307, 2001
21. Malhotra A, Kang BPS, Opawumi D, Belizaire W, Meggs LG: Molecular biology of protein kinase C signaling in cardiac myocytes. Mol Cell Biochem 225: 97-107, 2001
22. Taegtmeyer H, McNulty P, Young M: Adaptation and maladaptation of the heart in diabetes. Part I: General concepts. Circulation 105: 1727-1733, 2002
23. Kolter T, Uphues I, Eckel J: Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 273: E59-E67, 1997
24. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998
25. Malhotra A, Kang BPS, Cheung S, Opawumi D, Meggs LG: Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of Troportin I. Diabetes 50: 1918-1926, 2001
26. Yasumari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J: Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ Res 81: 953-962, 1997
27. McClain DA, Crook ED: Hexosamines and insulin resistance. Diabetes 45: 1003-1009, 1996
28. Filippis A, Clark S, Proietto J: Increased flux through the hexosamine bioshynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem J 324: 981-985, 1997
29. Eckel J, Reinauer H: Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes-induced alterations. Biochem Soc Trans 18: 1125-1127, 1990
30. Ren J, Davidoff AJ: α2-Heremans Schmid glycoprotien, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction. Diabetes Metab Res Rev 18: 305-310, 2002
31. Young ME, McNulty P, Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms. Circulation 105: 1861-1870, 2002
32. Tahiliani AG, McNeill JH: Effects of insulin perfusion and altered glucose concentrations on heart function in 3-day and 6-week diabetic rats. Can J Physiol Pharmacol 64: 188-192, 1986
33. Chatham JC, Gao Z-P, Forder JR: Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Am J Physiol 277: E342-E351, 1999
34. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ, Taegtmeyer H: Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32: 985-996, 2000
35. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109: 629-639, 2002
36. Ren J, Sowers JR, Walsh MF, Brown RA: Reduced contractile response to insulin and IGF-1 in ventricular myocytes from genetically obese Zucker rats. Am J Physiol 279: H1708-H1714, 2000
37. Eckel J, Wirdeier A, Herberg L, Reinauer H: Insulin resistance in the heart: Studies on isolated cardiocytes of genetically obese Zucker rats. Endocrinology 116: 1529-1534, 1985
38. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE: Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98: 33-39, 2002
39. Davidson MB, Ren J, Vlahos CJ, Davidoff AJ: PKCβ is elevated in high [glucose]-induced daibetic-like cardiomyopathy. Diabetes 49: A447, 2000
40. Ren J, Duan J, Hintz KK, Ren BH: High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: Role of Akt and ERK activation. Cardiovasc Res 57: 738-748, 2003
41. Farese RV: Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol 283: E1-E11, 2002
42. Liu LS, Tanaka H, Ishii S, Eckel J: The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes. Endocrinology 139: 4531-4589, 1998
43. Bähr M, Spelleken M, Bock M, von Holtey M, Kiehn R, Eckel J: Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. Diabetologia 39: 766-774, 1996
44. Cooksey RC, Hebert Jr LF, Zhu J-H, Wofford P, Garvey WT, McClain DA: Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 140: 1151-1157, 1999
45. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ: Troglitazone attenuates high glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes 45: 1822-1825, 1996
46. 2+ transients in adult rat ventricular myocytes. Diabetes 48: 2059-2065, 1999